Reply to M.C. Chamberlain
Publication
, Journal Article
Heimberger, AB; Bigner, DD; Herndon, JE; Sampson, JH
Published in: Journal of Clinical Oncology
June 10, 2011
Duke Scholars
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
June 10, 2011
Volume
29
Issue
17
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Heimberger, A. B., Bigner, D. D., Herndon, J. E., & Sampson, J. H. (2011). Reply to M.C. Chamberlain. Journal of Clinical Oncology, 29(17). https://doi.org/10.1200/JCO.2010.34.1453
Heimberger, A. B., D. D. Bigner, J. E. Herndon, and J. H. Sampson. “Reply to M.C. Chamberlain.” Journal of Clinical Oncology 29, no. 17 (June 10, 2011). https://doi.org/10.1200/JCO.2010.34.1453.
Heimberger AB, Bigner DD, Herndon JE, Sampson JH. Reply to M.C. Chamberlain. Journal of Clinical Oncology. 2011 Jun 10;29(17).
Heimberger, A. B., et al. “Reply to M.C. Chamberlain.” Journal of Clinical Oncology, vol. 29, no. 17, June 2011. Scopus, doi:10.1200/JCO.2010.34.1453.
Heimberger AB, Bigner DD, Herndon JE, Sampson JH. Reply to M.C. Chamberlain. Journal of Clinical Oncology. 2011 Jun 10;29(17).
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
June 10, 2011
Volume
29
Issue
17
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences